Evidence map›Paper›PMID 25246557›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Bimodal activation of BubR1 by Bub3 sustains mitotic checkpoint signaling.

Joo Seok Han, Benjamin Vitre, Daniele Fachinetti, Don W Cleveland

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Research progress of Bub3 gene in malignant tumors.Cell biology international · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Spindle assembly checkpoint activation and silencing at kinetochores.Seminars in cell & developmental biology · 2021
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 2 countries.

Joo Seok HanLudwig Institute for Cancer Research and Departments of Cellular and Molecular Medicine and dcleveland@ucsd.edu j3han@ucsd.edu.
Benjamin VitreLudwig Institute for Cancer Research and Departments of Cellular and Molecular Medicine and.
Daniele FachinettiLudwig Institute for Cancer Research and Departments of Cellular and Molecular Medicine and.
Don W ClevelandLudwig Institute for Cancer Research and Departments of Cellular and Molecular Medicine and Medicine, University of California, San Diego, La Jolla, CA 92093 dcleveland@ucsd.edu j3han@ucsd.edu.
Ludwig Cancer Research · BE

Funding

U of Calif, San Diego Neuroscience Microscopy ImagingP30NS047101 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GLEESON, JOSEPH G, ZHENG, BINHAI · 2003 to 2022
$9.0M
MICROTUBULE REGULATIONR01GM029513 · NIGMS · LUDWIG INSTITUTE FOR CANCER RES LTD · PI CLEVELAND, DON W · 1985 to 2016
$8.2M
HIGHLY OXIDIZED THIOLATE HEMES--THEORY AND EXPERIMENTF32GM020513 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI GREEN, MICHAEL T · 2000 to 2001
$73k
NIGMS NIH HHS F32 GM020513NIGMS NIH HHS GM20513NIGMS NIH HHS R01 GM029513NINDS NIH HHS P30 NS047101
6 · The paper itself

Abstract

The mitotic checkpoint (also known as the spindle assembly checkpoint) prevents premature anaphase onset through generation of an inhibitor of the E3 ubiquitin ligase APC/C, whose ubiquitination of cyclin B and securin targets them for degradation. Combining in vitro reconstitution and cell-based assays, we now identify dual mechanisms through which Bub3 promotes mitotic checkpoint signaling. Bub3 enhances signaling at unattached kinetochores not only by facilitating binding of BubR1 but also by enhancing Cdc20 recruitment to kinetochores mediated by BubR1's internal Cdc20 binding site. Downstream of kinetochore-produced complexes, Bub3 promotes binding of BubR1's conserved, amino terminal Cdc20 binding domain to a site in Cdc20 that becomes exposed by initial Mad2 binding. This latter Bub3-stimulated event generates the final mitotic checkpoint complex of Bub3-BubR1-Cdc20 that selectively inhibits ubiquitination of securin and cyclin B by APC/C(Cdc20). Thus, Bub3 promotes two distinct BubR1-Cdc20 interactions, involving each of the two Cdc20 binding sites of BubR1 and acting at unattached kinetochores or cytoplasmically, respectively, to facilitate production of the mitotic checkpoint inhibitor.

Indexed as

Anaphase-Promoting Complex-CyclosomeBinding SitesCdc20 ProteinsCell Cycle ProteinsCell Line, TumorCyclin B1Fluorescence Recovery After PhotobleachingGreen Fluorescent ProteinsHeLa CellsHumansKinetochoresMicroscopy, FluorescenceM Phase Cell Cycle CheckpointsMutationPoly-ADP-Ribose Binding ProteinsProtein BindingAnaphase-Promoting Complex-CyclosomeBUB1 protein, humanBUB3 protein, humanCDC20 protein, humanCdc20 ProteinsCell Cycle ProteinsCyclin B1Green Fluorescent ProteinsPoly-ADP-Ribose Binding ProteinsProtein Serine-Threonine Kinases

Identifiers

PMID25246557
PMCPMC4210015
OpenAlexW2116439730

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.